These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27582128)

  • 1. Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India.
    Kumar Bhat N; Ahuja V; Dhar M; Ahmad S; Pandita N; Gupta V; Chandra S
    J Trop Pediatr; 2017 Apr; 63(2):104-108. PubMed ID: 27582128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
    Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
    Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. North Indian state of Uttarakhand: a new hothouse of visceral leishmaniasis.
    Ahmad S; Chandra H; Bhat NK; Dhar M; Shirazi N; Verma SK
    Trop Doct; 2016 Apr; 46(2):111-3. PubMed ID: 26466848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
    Thakur CP; Dedet JP; Narain S; Pratlong F
    Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kala-Azar at high altitude.
    Mahajan SK; Machhan P; Kanga A; Thakur S; Sharma A; Prasher BS; Pal LS
    J Commun Dis; 2004 Jun; 36(2):117-20. PubMed ID: 16295673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory study of kala-azar in children in Nepal.
    Singh K; Singh R; Parija SC; Faridi MM; Bhatta N
    J Trop Pediatr; 1999 Apr; 45(2):95-7. PubMed ID: 10341503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kala-azar: experience from a non-endemic area in India.
    Chandra J; Anand V; Patwari AK; Mandal RN; Aneja S; Sharma D
    J Trop Pediatr; 1995 Oct; 41(5):298-300. PubMed ID: 8531263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala azar--diagnostic dilemma.
    Raman TS; Ahuja SA; Mani KV; Jalpota YP; Adaval SK
    Indian Pediatr; 1992 Aug; 29(8):1036-9. PubMed ID: 1334051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Visceral leishmaniasis. Personal observation and review of epidemiology, clinical aspects and therapy].
    Dickerhoff R; Müller A; Bode U
    Klin Padiatr; 1990; 202(5):347-51. PubMed ID: 2170739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kala-azar in Uttar Pradesh--a study of 66 patients.
    Mittal V; Singh VK; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to treatment in Kala-azar: speciation of isolates from northeast India.
    Sundar S; Pai K; Kumar R; Pathak-Tripathi K; Gam AA; Ray M; Kenney RT
    Am J Trop Med Hyg; 2001 Sep; 65(3):193-6. PubMed ID: 11561703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
    Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
    Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S ; Kumar J; Singh R; Dwivedi SN
    Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of post kala-azar dermal leishmaniasis in India.
    Tripathy K; Misra A; Mallik R; Misra D; Rout N; Rath J
    Korean J Parasitol; 2010 Sep; 48(3):245-6. PubMed ID: 20877504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya.
    Mueller YK; Kolaczinski JH; Koech T; Lokwang P; Riongoita M; Velilla E; Brooker SJ; Chappuis F
    Am J Trop Med Hyg; 2014 Jan; 90(1):33-39. PubMed ID: 24218406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB; Yang CM; Zhang CJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.